标题 |
Phase 1/2 Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas
Aurora激酶A抑制剂Alisertib和Pembrolizumab治疗难治性Rb缺陷型头颈部鳞状细胞癌的1/2期研究
|
网址 | |
DOI | |
其它 |
期刊:Clinical Cancer Research 作者:Faye M. Johnson; Madison P. O'Hara; Lacin Yapindi; Peixin Jiang; Hai T. Tran; et al 出版日期:2024 |
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |